• 1
    Dattilo JB, Makhoul RG. The role of nitric oxide in vascular biology and pathobiology. Ann Vasc Surg 1997;11:307314.
  • 2
    Katz SD. The role of endothelium-derived vasoactive substances in the pathophysiology of exercise intolerance in patients with congestive heart failure. Prog Cardiovasc Dis 1995;38:2350.
  • 3
    Kaiser L., Spickard RC, Olivier NB. Heart failure depresses en-dothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962H967.
  • 4
    Kubo SH, Rector TS, Bank AJ, et al. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:15891596.
  • 5
    Drexler H. Endothelium as a therapeutic target in heart failure. Circulation 1998;98:26522655.
  • 6
    Nakamura M., Yoshida H., Arakawa N., et al. Endothelium-de-pendent vasodilation is not selectively impaired in patients with chronic heart failure secondary to valvular heart disease and congenital heart disease. Eur Heart J 1996;17:18751881.
  • 7
    Bank AJ, Lee PC, Kubo SH. Endothelial dysfunction in patients with heart failure: Relationship to disease severity. J Card Fail 2000; 6:2936.
  • 8
    Pedersen HD. Mitral Valve Prolapse in the dog. Pathogenesis, Pathophysiology, Diagnosis and Comparative Aspects of Early Myx-omatous Mitral Valve Disease. Copenhagen , Denmark : The Royal Veterinary and Agricultural University; 2000.
  • 9
    Pedersen HD, Häggström J. Mitral valve prolapse in the dog: A model of mitral valve prolapse in man. Cardiovasc Res 2000; 47: 234243.
  • 10
    Pedersen HD, Lorentzen KA, Kristensen BØ. Echocardiograph-ic mitral valve prolapse in Cavalier King Charles Spaniels: Epidemiology and prognostic significance for regurgitation. Vet Rec 1999; 144: 315320.
  • 11
    Pedersen HD, Kristensen BØ, Lorentzen KA, et al. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study. Can J Vet Res 1995; 59: 294298.
  • 12
    Pedersen HD, Häggström J., Olsen LH, et al. Idiopathic, asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an au-tosomal recessive trait. J Vet Intern Med 2002;16:169173.
  • 13
    Boudoulas H., Wooley CF. The floppy mitral valve, mitral valve prolapse and the mitral valve prolapse syndrome. In: BoudoulasH., WooleyCF, eds. Mitral Valve: Floppy Mitral Valve, Mitral Valve Prolapse, Mitral Valvular Regurgitation, 2nd ed. Armonk , NY : Futura Publishing Company; 2000: 617671.
  • 14
    Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1999;1411:273289.
  • 15
    Baylis C., Vallance P. Measurement of nitrite and nitrate levels in plasma and urine–What does this measure tell us about the activity of the endogenous nitric oxide system Curr Opin Nephrol Hypertens 1998;7:5962.
  • 16
    Moshage H., Kok B., Huizenga JR, Jansen PLM. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 1995;41:892896.
  • 17
    Wang J., Brown MA, Tam SH, et al. Effects of diet on measurement of nitric oxide metabolites. Clin Exp Pharmacol Physiol 1997;24:418420.
  • 18
    Zeballos GA, Bernstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 1995;91:29822988.
  • 19
    Rhodes PM, Leone AM, Francis PL, et al. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 1995;209:590596.
  • 20
    Jungersten L., Edlund A., Petersson AS, Wennmalm A. Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin Physiol 1996;16:369379.
  • 21
    Kittleson MD. Signalment, history, and physical examination. In: KittlesonMD, KienleRD, eds. Small Animal Cardiovascular Medicine. St Louis , MO : Mosby; 1998: 3646.
  • 22
    Häggström J., Hansson K., Karlberg BE. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgita-tion in Cavalier King Charles Spaniels. Am J Vet Res 1994; 55: 698703.
  • 23
    Kabuto H., Yamamoto M., Yokoi I., Ogawa N. The source of nitrate and nitrite contamination that interferes with their accurate estimation in blood. Clin Chim Acta 1997;266:199200.
  • 24
    Cornell CC, Kittleson MD, Della Torre P., et al. Allometric scaling of M-mode variables in normal adult dogs. 11th Annual Congress, European Society of Veterinary Internal Medicine, Dublin, Ireland, 2001.
  • 25
    Bernstein RD, Zhang X., Zhao G., et al. Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs. Nitric Oxide 1997;1:386396.
  • 26
    Belshaw BE. The differential diagnosis of polyuria/polydipsia in dogs. Vet Q 1995;17(Suppl 1):S19S21.
  • 27
    Olsen LH, Kristensen AT, Häggström J., et al. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse. J Vet Intern Med 2001;15:209216.
  • 28
    Brown CH 3rd, Leverett LB, Lewis CW, et al. Morphological, biochemical, and functional changes in human platelets subjected to shear stress. J Lab Clin Med 1975;86:462471.
  • 29
    Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001;88:756762.
  • 30
    Chandrasekar B., Tanguay JF. Platelets and restenosis. J Am Coll Cardiol 2000;35:555562.
  • 31
    Buchanan JW, Beardow AW, Sammarco CD. Femoral artery occlusion in Cavalier King Charles Spaniels. J Am Vet Med Assoc 1997;211:872874.
  • 32
    Karlstam E., Häggström J., Kvart C., et al. Pulmonary artery lesions in Cavalier King Charles Spaniels. Vet Rec 2000;147:166167.
  • 33
    Hambrecht R., Fiehn E., Weigl C., et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998;98:27092715.
  • 34
    Giannattasio C., Achilli F., Grappiolo A., et al. Radial artery flow-mediated dilation in heart failure patients. Effects of pharmacological and nonpharmacological treatment. Hypertension 2001; 38: 14511455.
  • 35
    Rector TS, Bank AJ, Mullen KA, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93:21352141.
  • 36
    Belardinelli R. Endothelial dysfunction in chronic heart failure: Clinical implications and therapeutic options. Int J Cardiol 2001; 81: 18.
  • 37
    Bauersachs J., Fraccarollo D., Galuppo P., et al. Endothelin-re-ceptor blockade improves endothelial vasomotor dysfunction in heart failure. Cardiovasc Res 2000;47:142149.
  • 38
    Halcox JPJ, Nour KRA, Zalos G., Quyyumi AA. Coronary va-sodilation and improvement in endothelial dysfunction with endothelin ETA receptor blockade. Circ Res 2001;89:969976.
  • 39
    Napoli R., Guardasole V., Matarazzo M., et al. Growth hormone corrects vascular dysfunction in patients with chronic heart failure. J Am Coll Cardiol 2002;39:9095.
  • 40
    Mow T., Pedersen HD. Increased endothelin-receptor density in myxomatous canine mitral valve leaflets. J Cardiovasc Pharmacol 1999;34:254260.